GlassScriptPhysician profile
Thomas P Carrigan
NPI 1912178641
$16,514.22
in general payments reported to CMS, 2019-2025
26 companies · $1,954 in 2025
The $1,954 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,205 · 2020: $425 · 2021: $447 · 2022: $5,621 · 2023: $762 · 2024: $3,100 · 2025: $1,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,701 · Travel and Lodging: $2,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,700.85 |
| Travel and Lodging | $2,115.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,994.61 | 2019-2025 | Watchman Access System |
| Biotronik INC. | $3,250.00 | 2019 | |
| Volta Medical INC | $3,134.59 | 2022 | |
| Abbott Laboratories | $2,162.92 | 2020-2025 | Aveir, Amplatzer Torqvue 45 X 45, Amplatzer Amulet |
| Biosense Webster, INC. | $1,543.17 | 2019-2025 | Carto 3, Na, Nuvision Ice Catheter |
| Medtronic, INC. | $893.25 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Pulseselect, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $209.41 | 2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $182.16 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.77 | 2022-2024 | Jardiance |
| Pfizer INC. | $150.49 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $141.71 | 2023-2025 | Camzyos |
| Merit Medical Systems INC | $105.77 | 2024 | Worley Adv Coronary Sinus Guide |
| Zoll Respicardia, INC. | $105.35 | 2022 | |
| Cvrx, INC. | $102.17 | 2021 | |
| Cardiofocus, INC. | $100.81 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $72.34 | 2022-2024 | Repatha |
| Cardiva Medical, INC. | $49.35 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $32.81 | 2025 | Mynx Control Venous |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.94 | 2020-2024 | Lifevest |
| Portola Pharmaceuticals, LLC | $27.05 | 2019 | |
| Medtronic USA, INC. | $21.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.71 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $13.73 | 2024 | Arcalyst |
| Angiodynamics, INC. | $12.05 | 2020 | |
| Itamar Medical INC | $10.38 | 2024 | Watchpatone |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Carrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.